Breast cancer (BC) is the most common malignancy (75-80%) among women. Options for management of BC are multivariate. Available modalities include surgery, radiotherapy, chemotherapy and hormone therapy. Despite availability of improved therapeutic adjuncts, mortality from BC is 40%. Vaccination strategies against BC are emerging as a viable alternative. This review highlights the available results of this emerging therapeutic strategy.
No takes yet. Share an insight, caveat, or question.
Das et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: